Name: Aaron Bloomer

New title: CFO, Exact Sciences

Previous title: Vice president, Baxter International

Bloomer will become the new CFO of Exact Sciences effective May 15, the company announced Monday. Earlier this year, current CFO Jeff Elliott announced plans to step down in 2024 for personal reasons. 

Bloomer has more than 15 years of experience in finance and accounting, previously leading financial planning, reporting and analytics (FP&A) for Baxter. Before that, he worked for 3M for more than a decade, including as senior vice president of FP&A and CFO for 3M China.

He joins Madison, Wisconsin-based Exact Sciences as it looks to grow adoption of its Cologuard screening test for colon cancer and its Oncotype DX test to predict the risk of breast cancer recurrence. The company is also working on a next-generation version of Cologuard and a blood test for colon cancer screening.

William Blair analyst Andrew Brackmann wrote in a research note that Bloomer seems to fit the bill for what the company was looking for in its next CFO. 

“There is no doubt that Bloomer will have big shoes to fill, with Elliott seen as a trusted and highly talented leader, for which investors have gained immense trust in,” Brackmann wrote. “That said, Exact is a much stronger entity today than when Elliott joined in 2016, with a broad infrastructure and global team in place, making this less about one hire and more about the entire team — all of which remains strong, in our view.”

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter.